NYSE:ALK - Post Discussion
Post by
Jannine on Apr 18, 2022 2:04am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!
Be the first to comment on this post